Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Mymetics Corporation
  6. Summary
    MYMX   US62856A1025

MYMETICS CORPORATION

(MYMX)
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Otc Markets
10/11/2021 10/12/2021 10/13/2021 10/14/2021 10/15/2021 Date
0.04755(c) 0.04725(c) 0.0496(c) 0.049(c) 0.04745(c) Last
13 906 33 250 17 555 10 000 10 665 Volume
+5.20% -0.63% +4.97% -1.21% -3.16% Change
More quotes
Estimated financial data (e)
Sales 2019 0,65 M 0,76 M 0,76 M
Net income 2019 -4,19 M -4,86 M -4,86 M
Net Debt 2019 58,2 M 67,6 M 67,6 M
P/E ratio 2019 -2,89x
Yield 2019 -
Sales 2020 0,67 M 0,77 M 0,77 M
Net income 2020 -4,16 M -4,82 M -4,82 M
Net Debt 2020 62,3 M 72,3 M 72,3 M
P/E ratio 2020 -5,77x
Yield 2020 -
Capitalization 12,4 M 14,4 M 14,4 M
EV / Sales 2019 106x
EV / Sales 2020 123x
Nbr of Employees 10
Free-Float 45,1%
More Financials
Company
Mymetics Corporation is a vaccine company. The Company is focused on developing vaccines for infectious diseases. The Company has over five vaccine candidates in its pipeline: human immunodeficiency virus type 1 (HIV-1)/acquired immune deficiency syndrome (AIDS), intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncitial Virus (RSV) vaccine. Its technology utilizes virosomes,... 
More about the company
All news about MYMETICS CORPORATION
08/16MYMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPER..
AQ
08/16Mymetics Corporation Reports Earnings Results for the Second Quarter Ended June 30, 202..
CI
06/17MYMETICS CORP : Changes in Registrant's Certifying Accountant (form 8-K)
AQ
05/18Mymetics Corporation Reports Earnings Results for the First Quarter Ended March 31, 202..
CI
03/31MYMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPER..
AQ
03/31Mymetics Corporation Reports Earnings Results for the Full Year Ended December 31, 2020
CI
03/23MYMETICS : Amendment to Quarterly Report (SEC Filing - 10-Q/A)
PU
03/23MYMETICS : Management's discussion and analysis of financial condition and results of oper..
AQ
2020MYMETICS : to advance Preclinical Studies for Virosome-based Covid-19 Vaccine through Inno..
PU
2020MYMETICS : Management's discussion and analysis of financial condition and results of oper..
AQ
2020Mymetics Corporation Reports Earnings Results for the Third Quarter Ended September 30,..
CI
2020MYMETICS : Starts Second Preclinical Study for Virosome-based Covid-19 vaccine
PU
2020Mymetics Corporation Reports Earnings Results for the Second Quarter Ended June 30, 202..
CI
2020Mymetics Corporation Reports Earnings Results for the First Quarter Ended March 31, 202..
CI
2020MYMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPER..
AQ
More news
News in other languages on MYMETICS CORPORATION

- No features available -

More news
Chart MYMETICS CORPORATION
Duration : Period :
Mymetics Corporation Technical Analysis Chart | MYMX | US62856A1025 | MarketScreener
Income Statement Evolution
Managers and Directors
Ronald Hugo Gerard Kempers President, Chief Executive & Financial Officer
Sylvain Fleury Chief Scientific Officer
Thomas Staehelin Independent Non-Executive Director
Ernest M. Stern Independent Non-Executive Director
Ulrich Burkhard Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MYMETICS CORPORATION-37.97%14
GILEAD SCIENCES, INC.16.08%84 795
WUXI APPTEC CO., LTD.29.45%66 184
BIONTECH SE203.83%59 820
REGENERON PHARMACEUTICALS14.52%57 519
VERTEX PHARMACEUTICALS-23.09%47 156